Gulersen M, Grunebaum A, Lenchner E, et al. - Via performing a retrospective cohort study using the US Natality Live Birth database from the Centers for Disease Control and Prevention for the years 2016–2017, researchers examined whether racial or ethnic disparity exist in the administration of antenatal corticosteroids (ACSs) in women with preterm births between 23 and 34 weeks of gestation. Among the included 183,084 preterm births between 23 and 34 weeks of gestation, 89,278 (48.8%) were non-Hispanic white, 50,140 (27.4%) were non-Hispanic black, and 43,666 (23.8%) were Hispanic. Per findings, there is a significant racial and ethnic disparity in the administration of ACSs before preterm births between 23 and 34 weeks of gestation. For lower administration of ACSs, following were independent risk factors: non-Hispanic black and Hispanic race and ethnicity. As non-Hispanic black women had the higher prevalence for preterm birth, the findings of suboptimal administration of ACSs in this population were of particular concern and might have significant neonatal health implications.